{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:02:46Z","timestamp":1783645366207,"version":"3.55.0"},"reference-count":52,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Causative germline missense mutations in the RET proto-oncogene have been associated with over 92% of families with the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN 2). MEN 2A is characterized primarily by medullary thyroid carcinoma (MTC) and pheochromocytoma, both tumors of neural crest origin. Parathyroid hyperplasia or adenoma is also seen in MEN 2A, but rarely in MEN 2B, which has additional stigmata, including a marfanoid habitus, mucosal neuromas, and ganglioneuromatosis of the gastrointestinal tract. In familial MTC, MTC is the only lesion present. Somatic RET mutations have also been identified in a subset of sporadic MTCs, pheochromocytomas, and rarely, small cell lung cancer, but not in sporadic parathyroid hyperplasias\/adenomas or other neuroendocrine tumors. Glial cell line-derived neurotrophic factor (GDNF) and its receptor molecule GDNFR-\u03b1, have recently been identified as members of the RET ligand binding complex. Therefore, the genes encoding both GDNF and GDNFR-\u03b1 are excellent candidates for a role in the pathogenesis of those MEN 2 families and sporadic neuroendocrine tumors without RET mutations. No mutations were found in the coding region of GDNF in DNA samples from 9 RET mutation negative MEN 2 individuals (comprising 6 distinct families), 12 sporadic MTCs, 17 sporadic cases of parathyroid adenoma, and 10 small cell lung cancer cell lines. Therefore, we find no evidence that mutation within the coding regions of GDNF plays a role in the genesis of MEN 2 and sporadic neuroendocrine tumors.<\/jats:p>","DOI":"10.1210\/jcem.82.9.4197","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:02:47Z","timestamp":1389200567000},"page":"3025-3028","source":"Crossref","is-referenced-by-count":21,"title":["Mutation Analysis of Glial Cell Line-Derived Neurotrophic Factor, a Ligand for an RET\/Coreceptor Complex, in Multiple Endocrine Neoplasia Type 2 and Sporadic Neuroendocrine Tumors"],"prefix":"10.1210","volume":"82","author":[{"given":"Debbie J.","family":"Marsh","sequence":"first","affiliation":[{"name":"Department of Adult Oncology (D.J.M., Z.Z., B.J.R., G.I.S., C.E.), Boston, MA;"},{"name":"Human Cancer Genetics Unit (D.J.M., Z.Z., C.E.), Boston, MA;"},{"name":"Dana-Farber Cancer Institute, Department of Medicine (D.J.M., Z.Z., A.A., B.J.R., G.I.S., C.E.), Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Adult Oncology (D.J.M., Z.Z., B.J.R., G.I.S., C.E.), Boston, MA;"},{"name":"Human Cancer Genetics Unit (D.J.M., Z.Z., C.E.), Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Arnold","sequence":"additional","affiliation":[{"name":"Human Cancer Genetics Unit (D.J.M., Z.Z., C.E.), Boston, MA;"},{"name":"Laboratory of Endocrine Oncology (A.A.), Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Andrew","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kolling Institute for Medical Research (S.D.A., D.L., B.G.R.), Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Learoyd","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kolling Institute for Medical Research (S.D.A., D.L., B.G.R.), Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Frilling","sequence":"additional","affiliation":[{"name":"Department of Surgery (A.F.), Eppendorf University of Hamburg, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Komminoth","sequence":"additional","affiliation":[{"name":"Department of Pathology (P.K.), University of Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut P.H.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Division of Nephrology (H.P.H.N.), Department of Internal Medicine IV, Albert-Ludwigs University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.J.","family":"Ponder","sequence":"additional","affiliation":[{"name":"CRC Human Cancer Genetics Research Group (B.A.J.P.), University of Cambridge, Cambridge, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrett J.","family":"Rollins","sequence":"additional","affiliation":[{"name":"Department of Adult Oncology (D.J.M., Z.Z., B.J.R., G.I.S., C.E.), Boston, MA;"},{"name":"Dana-Farber Cancer Institute, Department of Medicine (D.J.M., Z.Z., A.A., B.J.R., G.I.S., C.E.), Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Adult Oncology (D.J.M., Z.Z., B.J.R., G.I.S., C.E.), Boston, MA;"},{"name":"Dana-Farber Cancer Institute, Department of Medicine (D.J.M., Z.Z., A.A., B.J.R., G.I.S., C.E.), Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Kolling Institute for Medical Research (S.D.A., D.L., B.G.R.), Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois M.","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Paediatrics (L.M.M.), Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Eng","sequence":"additional","affiliation":[{"name":"Department of Adult Oncology (D.J.M., Z.Z., B.J.R., G.I.S., C.E.), Boston, MA;"},{"name":"Human Cancer Genetics Unit (D.J.M., Z.Z., C.E.), Boston, MA;"},{"name":"Dana-Farber Cancer Institute, Department of Medicine (D.J.M., Z.Z., A.A., B.J.R., G.I.S., C.E.), Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071619152888300_R1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium Analysis.","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"2020071619152888300_R2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM199609263351307","article-title":"The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung disease.","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071619152888300_R3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM196807042790101","article-title":"Syndrome of bilateral pheochromoctyoma, medullary thyroid carcinoma and multiple neuromas.","volume":"279","author":"Schimke","year":"1968","journal-title":"N Engl J Med"},{"key":"2020071619152888300_R4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1096\/fasebj.7.10.8102106","article-title":"The role of gene mutations in the genesis of familial cancers.","volume":"7","author":"Eng","year":"1993","journal-title":"FASEB J"},{"key":"2020071619152888300_R5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1995.tb01903.x","article-title":"Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.","volume":"43","author":"Eng","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071619152888300_R6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jmg.32.12.934","article-title":"Mutations of the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytoma.","volume":"32","author":"Eng","year":"1995","journal-title":"J Med Genet"},{"key":"2020071619152888300_R7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","article-title":"Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071619152888300_R8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/gcc.2870120308","article-title":"Mutation in the RET proto-oncogene in sporadic medullary thyroid carcinoma.","volume":"12","author":"Eng","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"2020071619152888300_R9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"key":"2020071619152888300_R10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/3.10.1895","article-title":"RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.","volume":"3","author":"Blaugrund","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071619152888300_R11","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","article-title":"Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTCs.","volume":"3","author":"Zedenius","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071619152888300_R12","first-page":"3088","article-title":"Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinoma.","volume":"80","author":"Zedenius","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619152888300_R13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19950801)76:3<479::AID-CNCR2820760319>3.0.CO;2-M","article-title":"Analysis of RET proto-oncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.","volume":"76","author":"Komminoth","year":"1995","journal-title":"Cancer"},{"key":"2020071619152888300_R14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2265.1996.681503.x","article-title":"Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.","volume":"44","author":"Marsh","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071619152888300_R15","first-page":"922","article-title":"Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.","volume":"145","author":"Komminoth","year":"1994","journal-title":"Am J Pathol"},{"key":"2020071619152888300_R16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2265.1995.tb02593.x","article-title":"Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas.","volume":"42","author":"Chew","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071619152888300_R17","first-page":"2063","article-title":"The RET proto-oncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.","volume":"80","author":"Beldjord","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619152888300_R18","first-page":"627","article-title":"Mutations in the RET protooncogene in sporadic pheochromocytomas.","volume":"80","author":"Lindor","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619152888300_R19","first-page":"2881","article-title":"Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.","volume":"81","author":"Hofstra","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619152888300_R20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1242\/dev.119.4.1005","article-title":"Expression of the c-ret proto-oncogene during mouse embryogenesis.","volume":"119","author":"Pachnis","year":"1993","journal-title":"Development"},{"key":"2020071619152888300_R21","first-page":"2711","article-title":"Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.","volume":"81","author":"Pausova","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619152888300_R22","first-page":"1600","article-title":"Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.","volume":"147","author":"Padberg","year":"1995","journal-title":"Am J Pathol"},{"key":"2020071619152888300_R23","first-page":"2041","article-title":"RET proto-oncogene point mutations in sporadic neuroendocrine tumors.","volume":"81","author":"Komminoth","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619152888300_R24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1096-9896(199610)180:2<138::AID-PATH652>3.0.CO;2-H","article-title":"Analysis of the RET proto-oncogene in sporadic parathyroid adenomas.","volume":"180","author":"Williams","year":"1996","journal-title":"J Pathol"},{"key":"2020071619152888300_R25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2183\/pjab.70.210","article-title":"A novel point mutation of the RET proto-oncogene in small cell lung carcinoma cell lines","volume":"70B","author":"Futami","year":"1994","journal-title":"Proc Jpn Acad."},{"key":"2020071619152888300_R26"},{"key":"2020071619152888300_R27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/geno.1995.1202","article-title":"The gene coding for glial cell line derived neurotrophic factor (GDNF) maps to chromosome 5p12\u2013p13.1.","volume":"28","author":"Schindelhauer","year":"1995","journal-title":"Genomics"},{"key":"2020071619152888300_R28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00210297","article-title":"Human glial cell line-derived neurotrophic factor (GDNF) maps to chromosome 5.","volume":"96","author":"Bermingham","year":"1995","journal-title":"Hum Genet"},{"key":"2020071619152888300_R29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/381789a0","article-title":"Glial cell line-derived neurotrophic factor signalling through the Ret receptor tyrosine kinase.","volume":"381","author":"Durbec","year":"1996","journal-title":"Nature"},{"key":"2020071619152888300_R30","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0092-8674(00)81311-2","article-title":"GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF.","volume":"85","author":"Jing","year":"1996","journal-title":"Cell"},{"key":"2020071619152888300_R31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/382080a0","article-title":"Characterization of a multicomponent receptor for GDNF.","volume":"382","author":"Treanor","year":"1996","journal-title":"Nature"},{"key":"2020071619152888300_R32","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopamingergic neurons.","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"2020071619152888300_R33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","article-title":"Genotype-phenotype correlation in MEN 2: report of the International RET Mutation Consortium.","volume":"238","author":"Mulligan","year":"1995","journal-title":"J Intern Med"},{"key":"2020071619152888300_R34","first-page":"310","article-title":"Mutation analysis of glial cell line-derived neurotrophic factor, GDNF, a ligand for the RET\/GDNF receptor a complex, in sporadic phaeochromocytomas.","volume":"57","author":"Dahia","year":"1997","journal-title":"Cancer Res"},{"key":"2020071619152888300_R35"},{"key":"2020071619152888300_R36","first-page":"505","article-title":"Reciprocal RB inactivation and P16(Ink4) expression in primary lung cancers and cell lines.","volume":"55","author":"Shapiro","year":"1995","journal-title":"Cancer Res"},{"key":"2020071619152888300_R37","first-page":"3375","article-title":"Absence of p16INK4 protein is restricted to the subset of lung cancer cell lines that retains wildtype RB.","volume":"9","author":"Otterson","year":"1994","journal-title":"Oncogene"},{"key":"2020071619152888300_R38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.2838909","article-title":"Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.","volume":"241","author":"Harbour","year":"1988","journal-title":"Science"},{"key":"2020071619152888300_R39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/328524a0","article-title":"Deletion of genes on chromosome 1 in endocrine neoplasia.","volume":"328","author":"Mathew","year":"1987","journal-title":"Nature"},{"key":"2020071619152888300_R40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/381785a0","article-title":"Functional receptor for GDNF encoded by the c-ret proto-oncogene.","volume":"381","author":"Trupp","year":"1996","journal-title":"Nature"},{"key":"2020071619152888300_R41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-3468(67)80085-X","article-title":"Embryogenesis of intramural ganglia of the gut and its relation to Hirschsprung disease.","volume":"10","author":"Okamoto","year":"1967","journal-title":"J Pediatr Surg"},{"key":"2020071619152888300_R42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/367378a0","article-title":"Mutations of the RET proto-oncogene in Hirschsprung\u2019s disease.","volume":"367","author":"Edery","year":"1994","journal-title":"Nature"},{"key":"2020071619152888300_R43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/367377a0","article-title":"Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung\u2019s disease.","volume":"367","author":"Romeo","year":"1994","journal-title":"Nature"},{"key":"2020071619152888300_R44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/hmg\/4.5.821","article-title":"Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.","volume":"4","author":"Angrist","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071619152888300_R45","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/hmg\/4.8.1381","article-title":"Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.","volume":"4","author":"Attie\u0301","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071619152888300_R46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/382070a0","article-title":"Renal agenesis and the absence of enteric neurons in mice lacking GDNF.","volume":"382","author":"Sa\u0301nchez","year":"1996","journal-title":"Nature"},{"key":"2020071619152888300_R47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/382073a0","article-title":"Defects in enteric innervation and kidney development in mice lacking GDNF.","volume":"382","author":"Pichel","year":"1996","journal-title":"Nature"},{"key":"2020071619152888300_R48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/382076a0","article-title":"Renal and neuronal abnormalities in mice lacking GDNF.","volume":"382","author":"Moore","year":"1996","journal-title":"Nature"},{"key":"2020071619152888300_R49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1196-341","article-title":"Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.","volume":"14","author":"Angrist","year":"1996","journal-title":"Nature Genet"},{"key":"2020071619152888300_R50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1196-345","article-title":"Germline mutations of the RET ligand, GDNF, are not sufficient to cause Hirschsprung disease.","volume":"14","author":"Salomon","year":"1996","journal-title":"Nature Genet"},{"key":"2020071619152888300_R51","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/5.12.2023","article-title":"De novo mutation of GDNF, ligand for RET\/GDNFR-a receptor complex in Hirschsprung disease.","volume":"5","author":"Ivanchuk","year":"1996","journal-title":"Hum Mol Genet"},{"key":"2020071619152888300_R52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/384467a0","article-title":"Neurturin, a relative of glial-cell-line-derived neurotrophic factor.","volume":"384","author":"Kotzbauer","year":"1996","journal-title":"Nature"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/9\/3025\/9233361\/jcem3025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/9\/3025\/9233361\/jcem3025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:48:11Z","timestamp":1647906491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/82\/9\/3025\/2866054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9,1]]},"references-count":52,"aliases":["10.1210\/jc.82.9.3025"],"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.82.9.4197","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9,1]]}}}